The present study demonstrated that STAT3 promotes HER3 expression through the activation of G9a, which, in turn, represses HER3-targeted miR-145-5p expression in EGFR-positive lung cancers (Fig. 6). The gene discussed is STAT3; the disease is lung carcinoma.